CB

Iterative Health Named to the 2022 CB Insights’ Digital Health 150 List

Retrieved on: 
Wednesday, December 7, 2022
Medical Devices, Health, Technology, Clinical Trials, General Health, Artificial Intelligence, CB Insights, Digital technology, AR, Digital health, IBD, Patient, Gastroenterology, Digital, FDA, AI, Health, SVP, Colorectal cancer, Artificial intelligence, Multimedia, CB, Inflammatory bowel disease, Machine learning, Organization, Risk management, Medical device, Medical imaging

Iterative Health , a pioneer in precision-medicine technologies for gastroenterology, today announced that it has been named one of CB Insights top 150 companies in Digital Health for 2022, the second year in a row in which it has made this list.

Key Points: 
  • Iterative Health , a pioneer in precision-medicine technologies for gastroenterology, today announced that it has been named one of CB Insights top 150 companies in Digital Health for 2022, the second year in a row in which it has made this list.
  • The Digital Health 150 is CB Insights annual ranking of the 150 most promising digital health startups in the world.
  • View the full release here: https://www.businesswire.com/news/home/20221207005069/en/
    Iterative Health has been named one of CB Insights top 150 companies in Digital Health for 2022.
  • By marrying data, expert insights, and work management tools, clients manage their end-to-end technology decision-making process on CB Insights.

Abridge Named to the 2022 CB Insights’ Digital Health 150 List

Retrieved on: 
Wednesday, December 7, 2022
Consumer Electronics, Technology, Other Health, Health, Health Technology, Other Technology, Telecommunications, Software, Artificial Intelligence, Audio, Video, Telemedicine, Virtual Medicine, CB Insights, Digital technology, R, AR, Patient, Telehealth, Research, Digital, SVP, History, Multimedia, Digital health, Documentation, CB, Health, NLP, Pressure, Video game, Medicine, Retail, Medical device, Abridge, Mosaic

CB Insights today named Abridge, the leader in medical conversation AI, to its fourth-annual Digital Health 150 , showcasing the 150 most promising private digital health companies of 2022.

Key Points: 
  • CB Insights today named Abridge, the leader in medical conversation AI, to its fourth-annual Digital Health 150 , showcasing the 150 most promising private digital health companies of 2022.
  • View the full release here: https://www.businesswire.com/news/home/20221207005024/en/
    Abridge is a 2022 CB Insights' top digital health company.
  • (Graphic: Business Wire)
    "From reimagining clinical care, to leveraging tech like AR/VR to improve surgical training, this years Digital Health 150 winners are transforming the future of healthcare with digital technology, said Brian Lee, SVP of CB Insights Intelligence Unit.
  • Quick facts on the 2022 Digital Health 150:
    Equity funding and deals: Since 2017, this year's Digital Health 150 winners have raised around $5.6B in equity funding across 378 deals.

Ellipsis Health Named to the 2022 CB Insights' Digital Health 150 List

Retrieved on: 
Wednesday, December 7, 2022
CB Insights, Diagnosis, Digital technology, Human, R, AR, Economist Intelligence Unit, Science, Research, Digital, Monitoring, AI, Health, SVP, Mental health, History, Multimedia, Digital health, CB, SAN, Depression, Machine learning, Anxiety, Medical imaging, Medicine, Retail, Mosaic

SAN FRANCISCO, Dec. 7, 2022 /PRNewswire/ -- Ellipsis Health, the market leader in AI-generated vocal biomarker technology, today announced it has been named to CB Insights fourth-annual Digital Health 150, showcasing the 150 most promising private digital health companies of 2022.

Key Points: 
  • Recognized for achievements in Screening, Monitoring and Diagnostics
    SAN FRANCISCO, Dec. 7, 2022 /PRNewswire/ -- Ellipsis Health , the market leader in AI-generated vocal biomarker technology, today announced it has been named to CB Insights fourth-annual Digital Health 150 , showcasing the 150 most promising private digital health companies of 2022.
  • "We are proud to be named to CB Insights' Digital Health 150 as it reflects the strength of our technology, the depth of our science, as well as the many ways in which the Ellipsis Health team is creating a new standard for earlier and better identification, assessment, and monitoring of mental health," said Mainul Mondal, CEO, Ellipsis Health.
  • Quick facts on the 2022 Digital Health 150:
    Equity funding and deals: Since 2017, this year's Digital Health 150 winners have raised around $5.6B in equity funding across 378 deals.
  • Ellipsis Health was founded with the belief that a person's mental health should have the same priority as one's physical health.

AM Best Affirms Credit Ratings of Chubb Limited and Its Subsidiaries

Retrieved on: 
Thursday, December 1, 2022
Insurance, Professional Services, NYSE, Combined, Bermuda, AM Best, ACE, Credit, ALL, Health, Long-term care insurance, Combined Insurance, News, Insurance, Life, Chubb Limited, ERM, Share repurchase, CB, Risk management, FSR, Acquisition, Environment, Superior, Risk, AM, Fortune 1000, Long-Term Capital Management, Reinsurance

Lastly, AM Best has affirmed the Long-Term ICRs of a+ (Excellent) and the Long-Term Issue Credit Ratings (Long-Term IR) of Chubb Limited (CB) and Chubb INA Holdings Inc.

Key Points: 
  • Lastly, AM Best has affirmed the Long-Term ICRs of a+ (Excellent) and the Long-Term Issue Credit Ratings (Long-Term IR) of Chubb Limited (CB) and Chubb INA Holdings Inc.
  • The ratings of Chubb Bermuda also reflect the implicit support received from Chubb Limited, the ultimate parent.
  • For additional information regarding the use and limitations of Credit Rating opinions, please view Guide to Best's Credit Ratings .
  • For information on the proper use of Bests Credit Ratings, Bests Performance Assessments, Bests Preliminary Credit Assessments and AM Best press releases, please view Guide to Proper Use of Bests Ratings & Assessments .

Provectus Biopharmaceuticals Announces New Data from Combination Therapy Trial of Small Molecule Cancer Immunotherapy PV-10® and Keytruda® for First-Line Stage III Melanoma at Melanoma Bridge 2022

Retrieved on: 
Thursday, December 1, 2022
Merck Sharp & Dohme Federal Credit Union, API, Doctor of Philosophy, HX, CR, Dermatology, Wound healing, CB, WHO, Merck & Co., III, The Retreat, CRS, INN, Melanoma, Patient, Merck, Pembrolizumab, Ophthalmology, World Health Organization, Disease, RBS, Hematology, International, Infection, OS, PFS, Cell death, NIH, ClinicalTrials.gov, OTCQB, Engineered wood, Birth control, Pharmaceutical industry, Vaccine, Renewable energy, Tanning (leather), U.S.A

This trial is essentially a head-to-head comparison of PV-10 combination therapy and monotherapy Keytruda.

Key Points: 
  • This trial is essentially a head-to-head comparison of PV-10 combination therapy and monotherapy Keytruda.
  • Importantly, Provectus pharmaceutical-grade RBS displays different therapeutic effects at different concentrations and can be formulated for delivery by different routes of administration.
  • Secondly, multivariate immune signaling, activation, and response may follow that may manifest as stimulatory, inhibitory, or both.
  • Information about the Companys clinical trials can be found at the National Institutes of Health (NIH) registry, www.clinicaltrials.gov .

Biz2Credit Named to the Deloitte Technology Fast 500, Inc. 5000, and Fintech 250 Lists for 2022, Wins ‘Great Place to Work’ Certification

Retrieved on: 
Wednesday, November 30, 2022
Nexus, Growth, Place, CB, Biz2credit, Inc., Deloitte Technology Fast 500, Intuit, Certification, Database, Science and technology in Asia, Metric space, Small business, Trust, Financial technology, Telecommunication, Health, Microsoft, Video game, Mosaic

The Deloitte list recognizes the fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America.

Key Points: 
  • The Deloitte list recognizes the fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America.
  • Biz2Credit was honored at the 2022 Deloitte Technology Fast 500 ceremony in New York on Tuesday, Nov. 15.
  • Biz2Credit has also been named to CB Insights fifth annual Fintech 250 , a list of the top private fintech companies using technology to transform financial services.
  • Biz2Credit this month was also recognized as a Great Place to Work for the third year in a row.

Petrofac Limited: PETROFAC MANAGEMENT AND BOARD CHANGES

Retrieved on: 
Sunday, November 27, 2022
MENA, Growth, CB, Tariq, London Stock Exchange, McDermott, Consolidated Contractors Company, University, Listing Rules, Construction, Development, KBR, Master, Senior, PFC, International, EPC, Master's degree, MAR, CB&I, Tufts University, Management, Oil, Engineering, Science

Petrofac Limited (Petrofac or the Company) announces today that Sami Iskander, Group Chief Executive, will leave the business at the end of March 2023 in order to pursue other interests.

Key Points: 
  • Petrofac Limited (Petrofac or the Company) announces today that Sami Iskander, Group Chief Executive, will leave the business at the end of March 2023 in order to pursue other interests.
  • Tareq will also be appointed as an Executive Director to Petrofacs Board of Directors at that time.
  • We are delighted that Tareq Kawash has agreed to join the Board as our new Group Chief Executive.
  • Tareq Kawash said: I have known Petrofac throughout my career and have always admired its unique execution capability.

Quantum FinTech Acquisition Corporation to Acquire AtlasClear

Retrieved on: 
Wednesday, November 16, 2022
Depository Trust & Clearing Corporation, Attention, Risk, FSB, CBDO, Security (finance), Vii, Section 14 of the Canadian Charter of Rights and Freedoms, Federal, SALT, Proxy, Communication, IR, Prospectus, Q2, Person, COVID-19, SPAC, FICC, Financial Industry Regulatory Authority, WDCO, Annual report, Financial technology, NYSE, Commercial, Form, Failure, Acquisition, CB, Securities Investor Protection Corporation, Federal Reserve Reform Act of 1977, Federal Reserve, Clearing Corporation, Sale, Risk management, Financial services, Bank, Cryptocurrency

TAMPA and SALT LAKE CITY, Nov. 16, 2022 (GLOBE NEWSWIRE) -- AtlasClear, Inc. (“AtlasClear”), Atlas Fintech Holdings Corp. (“Atlas FinTech”) and Quantum FinTech Acquisition Corporation (“QFTA”) (NYSE: QFTA), a publicly traded special purpose acquisition company, today announced that they have entered into a definitive business combination agreement that will result in Atlas FinTech transferring its trading technology assets to AtlasClear and the acquisition by AtlasClear as part of the initial business combination of Wilson Davis & Co., Inc., a correspondent clearing broker-dealer (“WDCO”). AtlasClear has also entered into a definitive agreement to acquire a federal reserve member following consummation of the initial business combination, expected in the second or third quarter of 2023. 

Key Points: 
  • AtlasClear will operate through an acquisition of technology assets from Atlas Fintech Holdings Corp., combined with the acquisition of correspondent clearing broker dealer, Wilson Davis & Co., Inc.
    AtlasClear also party to definitive agreement to acquire Federal Reserve Member, Commercial Bancorp of Wyoming; acquisition expected to close Q2 or Q3 2023 subject to regulatory approvals
    Robert McBey, CEO of Wilson Davis & Co., Inc., and Craig Ridenhour, Chief Business Development Officer of Atlas FinTech Holdings Corp., will lead the combined company
    TAMPA and SALT LAKE CITY, Nov. 16, 2022 (GLOBE NEWSWIRE) -- AtlasClear, Inc. (AtlasClear), Atlas Fintech Holdings Corp. (Atlas FinTech) and Quantum FinTech Acquisition Corporation (QFTA) (NYSE: QFTA), a publicly traded special purpose acquisition company, today announced that they have entered into a definitive business combination agreement that will result in Atlas FinTech transferring its trading technology assets to AtlasClear and the acquisition by AtlasClear as part of the initial business combination of Wilson Davis & Co., Inc., a correspondent clearing broker-dealer (WDCO).
  • AtlasClear is expected to possess best in class FinTech capabilities for its target marketplace in trading, clearing and settling financial products.
  • Together, we believe this business combination will advance our vision to create a FinTech forward alternative for market participants, said Craig Ridenhour, CBDO of Atlas FinTech Holdings.
  • Quantum FinTech Acquisition Corporation is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, that was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses, with a principal focus on identifying high-growth financial services and fintech businesses as targets.

The Providence Group Awarded Two OBIE Awards

Retrieved on: 
Tuesday, November 15, 2022
Marketing, Communism in 20 years, Melvyn Maxwell and Sara Stein Smith House, CB, OAAA OBIE Awards, Restaurant, Green Brick Partners, Obie Award, Life, Community, Pond, NYSE, Maxwell, Name, Acquisition, Entertainment, Building, HOA

The Providence Group is one of Green Brick Partners, Inc.s (Green Brick) subsidiary homebuilder brands.

Key Points: 
  • The Providence Group is one of Green Brick Partners, Inc.s (Green Brick) subsidiary homebuilder brands.
  • The GAHBA recognized The Providence Group with the award for Mixed Use Community of the Year for The Maxwell and Detached Community of the Year for Idylwilde.
  • The OBIE Awards are the premier awards in Atlantas home construction industry, celebrating commitment to innovation and excellence in new home building, development, remodeling, and marketing categories.
  • The Providence Group is one of Atlantas most respected names in homebuilding, known for well-crafted new homes with a personal touch.

Prove Identity Recognized as Only Company to Make Deloitte’s Technology Fast 500™ List for Six Consecutive Years in Tri-State Area

Retrieved on: 
Wednesday, November 16, 2022
Online Privacy, Apps, Applications, Technology, Mobile, Wireless, Security, Fintech, Professional Services, Software, Data Management, Deloitte Technology Fast 500, Health, Privacy, Friction, Compare Group, Telecommunication, Finance, Science and technology in Asia, Growth, Research, CB, Cryptocurrency

Prove Identity, Inc. (Prove), the leader in digital identity, today announced it has been named to Deloittes Technology Fast 500 , a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America, for the sixth year in a row.

Key Points: 
  • Prove Identity, Inc. (Prove), the leader in digital identity, today announced it has been named to Deloittes Technology Fast 500 , a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America, for the sixth year in a row.
  • Prove is one of only 14 companies on the 2022 list to have made the list six times or more, and is the only company in the tri-state region that has made the list six consecutive times.
  • The digital identity solutions market is set to reach $116 Billion by 2030 (Source: Straits Research).
  • Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2018 to 2021.